These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 20382349)
61. Hypertensive heart disease. Rafique N J Pak Med Assoc; 1993 Mar; 43(3):43-4. PubMed ID: 8326666 [No Abstract] [Full Text] [Related]
62. Immune mechanisms in atherosclerosis and potential for an atherosclerosis vaccine. Chyu KY; Nilsson J; Shah PK Discov Med; 2011 May; 11(60):403-12. PubMed ID: 21616039 [TBL] [Abstract][Full Text] [Related]
63. Current clinical pathophysiologic considerations in essential hypertension. Frohlich ED Med Clin North Am; 1997 Sep; 81(5):1113-29. PubMed ID: 9308601 [TBL] [Abstract][Full Text] [Related]
64. Primary hypertension in children and adolescents is an immuno-metabolic disease with hemodynamic consequences. Litwin M; Michałkiewicz J; Gackowska L Curr Hypertens Rep; 2013 Aug; 15(4):331-9. PubMed ID: 23737217 [TBL] [Abstract][Full Text] [Related]
65. Inflammation markers in essential hypertension. Tsounis D; Bouras G; Giannopoulos G; Papadimitriou C; Alexopoulos D; Deftereos S Med Chem; 2014; 10(7):672-81. PubMed ID: 25102200 [TBL] [Abstract][Full Text] [Related]
66. Immune system alterations by aldosterone during hypertension: from clinical observations to genomic and non-genomic mechanisms leading to vascular damage. Muñoz-Durango N; Barake MF; Letelier NA; Campino C; Fardella CE; Kalergis AM Curr Mol Med; 2013 Jul; 13(6):1035-46. PubMed ID: 23590758 [TBL] [Abstract][Full Text] [Related]
67. Immunological Aspects of Hypertension. Carnevale D; Lembo G High Blood Press Cardiovasc Prev; 2016 Jun; 23(2):91-5. PubMed ID: 27080378 [TBL] [Abstract][Full Text] [Related]
68. Resolution of inflammation, an active process to restore the immune microenvironment balance: A novel drug target for treating arterial hypertension. Zhang J; Liu S; Ding W; Wan J; Qin JJ; Wang M Ageing Res Rev; 2024 Aug; 99():102352. PubMed ID: 38857706 [TBL] [Abstract][Full Text] [Related]
70. Stress-dependent hypertension and the role of T lymphocytes. Marvar PJ; Harrison DG Exp Physiol; 2012 Nov; 97(11):1161-7. PubMed ID: 22941978 [TBL] [Abstract][Full Text] [Related]
71. Impact of inflammation on vascular disease in hypertension. Virdis A; Dell'Agnello U; Taddei S Maturitas; 2014 Jul; 78(3):179-83. PubMed ID: 24846805 [TBL] [Abstract][Full Text] [Related]
72. Do immune system changes have a role in hypertension? Fu ML J Hypertens; 1995 Nov; 13(11):1259-65. PubMed ID: 8984123 [TBL] [Abstract][Full Text] [Related]
73. Immune mechanisms in the pathophysiology of hypertension. Nguyen BA; Alexander MR; Harrison DG Nat Rev Nephrol; 2024 Aug; 20(8):530-540. PubMed ID: 38658669 [TBL] [Abstract][Full Text] [Related]
74. [Questions and answers on heart diseases. 3. Hypertensive heart diseases]. Takashina T; Gonai M Kangogaku Zasshi; 1979 Mar; 43(3):313-6. PubMed ID: 106160 [No Abstract] [Full Text] [Related]
76. The immunology of hypertension. Norlander AE; Madhur MS; Harrison DG J Exp Med; 2018 Jan; 215(1):21-33. PubMed ID: 29247045 [TBL] [Abstract][Full Text] [Related]
77. The immune system and hypertension. Dzielak DJ Hypertension; 1992 Jan; 19(1 Suppl):I36-44. PubMed ID: 1730453 [TBL] [Abstract][Full Text] [Related]
78. Modulating T Cell Phenotype and Function to Treat Hypertension. Fehrenbach DJ; Nguyen B; Alexander MR; Madhur MS Kidney360; 2023 Apr; 4(4):e534-e543. PubMed ID: 36951464 [TBL] [Abstract][Full Text] [Related]
79. The heart as a target organ of immune injury. Hastillo A; Willis HE; Hess ML Curr Probl Cardiol; 1991 Jun; 16(6):377-442. PubMed ID: 1914512 [TBL] [Abstract][Full Text] [Related]
80. Restraining immunity could lower high blood pressure. Leslie M Science; 2018 Mar; 359(6379):966-967. PubMed ID: 29496851 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]